维普中文期刊产品整合服务
54篇 您的检索式:作者名="Boidot"
    题名 作者 年代 出处 被引量
1Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-$ pathway that drives tumor angiogenesis 显示文摘Vegran F Boidot R Michiels C 2011Cancer Res2011,71,7:1
2Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer 显示文摘Vegran F Boidot R Oudin C 2007Oncogene2007,26,2:1
3Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours显示文摘Seront E Boidot R Bouzin C 2013Br J Cancer2013,109,10:1
4Transcriptional regulation of the survivin gene显示文摘Boidot R Végran F Lizard-Nacol S 2014Mol Biol Rep2014,41,1:1
5The role of telomeres in pre-dicting individual radiosensitivity of patients with cancer in the era ofpersonalized radiotherapy显示文摘Mirjolet C Boidot R Saliques S 2015Cancer Treat Rev2015,41,4:1
6Distinct expression of surviving splice variants in breast carcinomas显示文摘Vegran F Boidot R Oudin C 0,,:1
7Distinct expression of Survivin splice variants in breast carcinomas显示文摘Vegran F Boidot R Ouclin C 2005Int J Oncol2005,27,4:1
8Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy 显示文摘V6gran F Boidot R Oudin C 2006ClinCancerRes2006,12,19:1
9Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis 显示文摘VEGRN F BOIDOT R MICHIELS C 2011Cancer Res2011,71,7:1
10Overexpression of caspase-3s splicevariant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy 显示文摘Vegran F Boidot R Oudin C J 2006Cancer Therapy : Clinical2006,12,19:1
11, The transcription factor IRFI dictates the IL-21-dependent anticancer functions of TH9 cells显示文摘Vegran F Berger H Boidot R 2014Nat Immunol2014,15,8:1
12Lactate influx through the en- dothelial cell monocarboxylate transporter MCT1 supports an NF-KB/IL-8 pathway that drives tumor angiogenesis 显示文摘V6gran F Boidot R Michiels C 2011Cancer Res2011,71,7:1
13A short caspase-3 isoform inhibits chemotherapy- induced apoptosis by blocking apoptosome assembly显示文摘VEGRAN F BOIDOT R SOLARY E 2011PLoS One2011,6,29:1
14Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance显示文摘VEGRAN F BOIDOT R OUDIN C 2005Bull Cancer2005,92,3:1
15Implication of alternativesplice transcripts of caspase-3 and survivin in chemoresistance显示文摘Vegran F Boidot R Oudin C 2005Bull Cancer2005,92,3:1
16Distinct expression of survivin splice variants in breast carcinomas显示文摘Vegran F Boidot R Oudin C 2005Int J Oncol2005,27,4:1
17Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy显示文摘Boidot R Vegran F Lizard Naeol S 2009Int J Mol Med2009,23,2:1
18EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma显示文摘Pancreatic acinar cell carcinoma(PACC) is a rare cancer. When the tumor is metastatic, few therapeutic options are available. Precision medicine using next-generation sequencing is defined by the administration of drugs based on the tumor genetic mutations. The usage of precision medicine for finding new therapeutic options for rare cancers is an emerging field. We have reported here the case of a patient bearing a multitreated metastatic PACC. This patient underwent somatic and constitutional exome analyses. The analyses revealed in the liver metastasis an amplification of the EGFR gene. Accordingly, the patient was treated with off-label usage of panitumumab. We observed rapid response with necrosis of the liver metastasis, while no efficacy was observed in the primary tumor. An exome analysis of the primary tumor revealed amplification of HER2 and MET with EGFR amplification. Such amplifications are known as a resistance mechanism to anti EGFR therapy. Our results suggest that exome analysis may be helpful to highlight targets in rare cancers, such as PACC. EGFR amplification in this pathology should be determined and could be used as a biomarker to propose anti EGFR therapy.Corentin Richard Julie Niogret Romain Boidot Francois Ghiringhelli 2018World Journal of Gastrointestinal Oncology2018,10,4:1
19Pt-modified Ni aluminides, MCrAlY-base multilayer coatings and TBC systemsfabricated by Spark Plasma Sintering for the protection of Ni-base superalloys 显示文摘Monceau D Oquab D Estournes C Boidot M Selezneff S Thebault Y Cadoret Y Surface and Coatings Technology0,204,67:1
20Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer 显示文摘Vegran F Boidot R Oudin C 2007Oncogene2007,26,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费